163 related articles for article (PubMed ID: 37222921)
21. P2X7 and A
Medrano MP; Pisera-Fuster A; Bernabeu RO; Faillace MP
J Comp Neurol; 2020 Aug; 528(12):2000-2020. PubMed ID: 31997350
[TBL] [Abstract][Full Text] [Related]
22. The P2X7 receptor modulates immune cells infiltration, ectonucleotidases expression and extracellular ATP levels in the tumor microenvironment.
De Marchi E; Orioli E; Pegoraro A; Sangaletti S; Portararo P; Curti A; Colombo MP; Di Virgilio F; Adinolfi E
Oncogene; 2019 May; 38(19):3636-3650. PubMed ID: 30655604
[TBL] [Abstract][Full Text] [Related]
23. Tenovin-6 inhibits proliferation and survival of diffuse large B-cell lymphoma cells by blocking autophagy.
Yuan H; He M; Cheng F; Bai R; da Silva SR; Aguiar RC; Gao SJ
Oncotarget; 2017 Feb; 8(9):14912-14924. PubMed ID: 28118604
[TBL] [Abstract][Full Text] [Related]
24. Ecto-nucleotidases and nucleoside transporters mediate activation of adenosine receptors on hippocampal mossy fibers by P2X7 receptor agonist 2'-3'-O-(4-benzoylbenzoyl)-ATP.
Kukley M; Stausberg P; Adelmann G; Chessell IP; Dietrich D
J Neurosci; 2004 Aug; 24(32):7128-39. PubMed ID: 15306646
[TBL] [Abstract][Full Text] [Related]
25. The role of P2X7 receptor in PC12 cells after exposure to oxygen-glucose deprivation.
Fan B; Liu S; Xu C; Liu J; Kong F; Li G; Zhang C; Gao Y; Xu H; Yu S; Zheng C; Peng L; Song M; Wu B; Lv Q; Zou L; Ying M; Zhang X; Liang S
Auton Neurosci; 2014 Oct; 185():36-42. PubMed ID: 24746144
[TBL] [Abstract][Full Text] [Related]
26. Over-expression of Thioredoxin-1 mediates growth, survival, and chemoresistance and is a druggable target in diffuse large B-cell lymphoma.
Li C; Thompson MA; Tamayo AT; Zuo Z; Lee J; Vega F; Ford RJ; Pham LV
Oncotarget; 2012 Mar; 3(3):314-26. PubMed ID: 22447839
[TBL] [Abstract][Full Text] [Related]
27. High glucose inhibits osteogenic differentiation and proliferation of MC3T3‑E1 cells by regulating P2X7.
Yang J; Ma C; Zhang M
Mol Med Rep; 2019 Dec; 20(6):5084-5090. PubMed ID: 31702818
[TBL] [Abstract][Full Text] [Related]
28. Identification of PLA2G7 as a novel biomarker of diffuse large B cell lymphoma.
Zheng W; Lin Q; Issah MA; Liao Z; Shen J
BMC Cancer; 2021 Aug; 21(1):927. PubMed ID: 34404374
[TBL] [Abstract][Full Text] [Related]
29. ATP released by LPS increases nitric oxide production in raw 264.7 macrophage cell line via P2Z/P2X7 receptors.
Sperlágh B; Haskó G; Németh Z; Vizi ES
Neurochem Int; 1998 Sep; 33(3):209-15. PubMed ID: 9759915
[TBL] [Abstract][Full Text] [Related]
30. USP21 promotes cell proliferation by maintaining the EZH2 level in diffuse large B-cell lymphoma.
Ma H; Luo X; Zhou P; He N; Zhou J; Liu M; Xie W
J Clin Lab Anal; 2021 Mar; 35(3):e23693. PubMed ID: 33389794
[TBL] [Abstract][Full Text] [Related]
31. Fc receptor-like 1 (FCRL1) is a novel biomarker for prognosis and a possible therapeutic target in diffuse large B-cell lymphoma.
Yousefi Z; Sharifzadeh S; Zare F; Eskandari N
Mol Biol Rep; 2023 Feb; 50(2):1133-1145. PubMed ID: 36409389
[TBL] [Abstract][Full Text] [Related]
32. P2X7 Receptor Activity Limits Accumulation of T Cells within Tumors.
Romagnani A; Rottoli E; Mazza EMC; Rezzonico-Jost T; De Ponte Conti B; Proietti M; Perotti M; Civanelli E; Perruzza L; Catapano AL; Baragetti A; Tenedini E; Tagliafico E; Falzoni S; Di Virgilio F; Norata GD; Bicciato S; Grassi F
Cancer Res; 2020 Sep; 80(18):3906-3919. PubMed ID: 32699136
[TBL] [Abstract][Full Text] [Related]
33. Differential expression of the P2X7 receptor in ovarian surface epithelium during the oestrous cycle in the mouse.
Vázquez-Cuevas FG; Cruz-Rico A; Garay E; García-Carrancá A; Pérez-Montiel D; Juárez B; Arellano RO
Reprod Fertil Dev; 2013; 25(7):971-84. PubMed ID: 23050672
[TBL] [Abstract][Full Text] [Related]
34. TRPM7 is a molecular substrate of ATP-evoked P2X7-like currents in tumor cells.
Nörenberg W; Plötz T; Sobottka H; Chubanov V; Mittermeier L; Kalwa H; Aigner A; Schaefer M
J Gen Physiol; 2016 Jun; 147(6):467-83. PubMed ID: 27185858
[TBL] [Abstract][Full Text] [Related]
35. P2X7 nucleotide receptor activation enhances IFN gamma-induced type II nitric oxide synthase activity in BV-2 microglial cells.
Gendron FP; Chalimoniuk M; Strosznajder J; Shen S; González FA; Weisman GA; Sun GY
J Neurochem; 2003 Oct; 87(2):344-52. PubMed ID: 14511112
[TBL] [Abstract][Full Text] [Related]
36. Purinergic receptor modulation of lipopolysaccharide signaling and inducible nitric-oxide synthase expression in RAW 264.7 macrophages.
Hu Y; Fisette PL; Denlinger LC; Guadarrama AG; Sommer JA; Proctor RA; Bertics PJ
J Biol Chem; 1998 Oct; 273(42):27170-5. PubMed ID: 9765236
[TBL] [Abstract][Full Text] [Related]
37. LncRNA MALAT1 promotes tumorigenesis and immune escape of diffuse large B cell lymphoma by sponging miR-195.
Wang QM; Lian GY; Song Y; Huang YF; Gong Y
Life Sci; 2019 Aug; 231():116335. PubMed ID: 30898647
[TBL] [Abstract][Full Text] [Related]
38. PIK3CD promoted proliferation in diffuse large B cell lymphoma through upregulation of c-myc.
Cui W; Zheng S; Li X; Ma Y; Sang W; Liu M; Zhang W; Zhou X
Tumour Biol; 2016 Sep; 37(9):12767-12777. PubMed ID: 27448819
[TBL] [Abstract][Full Text] [Related]
39. microRNA‑196a‑3p inhibits cell proliferation and promotes cell apoptosis by targeting ADP ribosylation factor 4 in diffuse large B‑cell lymphoma.
Fu J; Lou X; Wan S; Zhao X; Chen Z; Zhu M; Guo L; Wu D; Wang S
Oncol Rep; 2021 Feb; 45(2):764-775. PubMed ID: 33416178
[TBL] [Abstract][Full Text] [Related]
40. Extracellular ATP/P2X7 receptor, a regulatory axis of migration in ovarian carcinoma-derived cells.
Nuñez-Ríos JD; Reyna-Jeldes M; Mata-Martínez E; Campos-Contreras ADR; Lazcano-Sánchez I; González-Gallardo A; Díaz-Muñoz M; Coddou C; Vázquez-Cuevas FG
PLoS One; 2024; 19(6):e0304062. PubMed ID: 38870128
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
